Long-Term Survival With Pembrolizumab Re-administration After Pseudo-Progression With Immune-Related Interstitial Lung Disease in a Patient With Non-small Cell Lung Cancer

Immune checkpoint inhibitors may cause specific immune-related reactions, such as pseudo-progression. In particular, malignant pleural effusion tends to worsen due to this phenomenon. However, the appropriate management in such cases is unclear. We report a 73-year-old man with advanced lung adenoca...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakashima, Koki, Demura, Yoshiki, Akai, Masaya, Ishizuka, Tamotsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8338124/
https://www.ncbi.nlm.nih.gov/pubmed/34367784
http://dx.doi.org/10.7759/cureus.16177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8338124/
https://www.ncbi.nlm.nih.gov/pubmed/34367784
http://dx.doi.org/10.7759/cureus.16177

Ejemplares similares